Capstone Investment Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Capstone Investment Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-32,679	Closed	-$2.36M	–	2039
2020 Q4	$2.36M	Buy	+32,679	New	+$1.71M	0.01%	827

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Capstone Investment Advisors's BEAT Position: Q1 2021 in Review

Capstone Investment Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 32,679 shares — an estimated $2.36M sold.

Capstone Investment Advisors first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $2.36M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Capstone Investment Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Capstone Investment Advisors sold 32,679 BioTelemetry, Inc. shares in Q1 2021, an estimated $2.36M.
Capstone Investment Advisors first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Capstone Investment Advisors's BioTelemetry, Inc. position peaked at $2.36M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Capstone Investment Advisors's 13F filing for Q1 2021, filed 17 May 2021.